Skip to main content

Table 1 Characteristics and outcomes of patients who underwent magnetic compression anastomosis for biliary complications after living-donor liver transplantation

From: Magnetic compression anastomosis for the complete dehiscence of hepaticojejunostomy in a patient after living-donor liver transplantation

Years

Author

No.

Age (years)

Sex

Disease

Reconstruction

Biliary complication

Intervention

Distance (mm)

Duration from LDLT (months)

Period until removal of magnet (days)

Duration of internal catheter (weeks)

Outcome

2005

Muraoka et al. [15]

1

1

F

FH

R-Y

Stricture

CJS

N/A

6

12

8

Success

  

2

57

M

LC

R-Y

Stricture

CJS

N/A

7

12

8

Success

2005

Okajima et al. [16]

3

44

F

FH

D-D

Obstruction

CCS

N/A

12

42

12

Success

2008

Akita et al. [17]

4

34

F

N/A

D-D

Obstruction

CCS

5

0

21

0

Success

2008

Mita et al. [18]

5

0.5

F

FH

R-Y

Obstruction

CJS

N/A

1.5

12

N/A

Success

  

6

59

F

LC

R-Y

Obstruction

CJS

N/A

5

25

N/A

Success

2009

Matsuno et al. [19]

7

53

M

N/A

D-D

Stricture

CCS

3

N/A

10

4.3

Success

2010

Marubashi et al. [13]

8

53

M

LC (HBV)

D-D

Dehiscence

CCS

N/A

6

63

72

Success

2010

Itoi et al. [20]

9

60

M

N/A

D-D

Obstruction

CCS

N/A

18

9

24

Success

2011

Kawakubo et al. [6]

10

56

M

LC (HCV)

R-Y

Obstruction

CJS

N/A

9

23

56

Success

2011

Jang et al. [14]

11

63

F

LC (HBV)

D-D

Stricture

CCS

N/A

71

42

83

Success

  

12

49

M

LC (HBV)

D-D

Stricture

CCS

N/A

6

26

70

Success

  

13

54

M

LC (HBV)

D-D

Stricture

CCS

N/A

55

18

49

Success

  

14

64

F

LC (HBV)

D-D

Stricture

CCS

N/A

71

71

14

Success

  

15

54

M

LC (HBV)

D-D

Stricture

CCS

N/A

15

102

26.7

Success

  

16

48

M

LC (HBV)

D-D

Stricture

CCS

N/A

13

102

25.7

Success

  

17

63

F

Liver failure (drug)

D-D

Stricture

CCS

30

107

Failure

  

18

33

M

Liver failure (HAV)

D-D

Stricture

CCS

N/A

5

33

26.7

Success

  

19

61

M

LC (HBV)

D-D

Stricture

CCS

N/A

4

14

25.4

Success

  

20

54

M

LC (HBV)

D-D

Stricture

CCS

N/A

9

181

7.3

Success

  

21

52

M

LC (HBV)

D-D

Stricture

CCS

N/A

1

153

N/A

Success

  

22

51

M

LC (HBV)

D-D

Stricture

CCS

N/A

5

Failure

2014

Uemura et al. [21]

23

49

F

LC (HCV)

D-D

Obstruction

CCS

11

11

24

13

Success

2016

Ersoz et al. [22]

24

37

M

LC (HBV)

D-D

Dehiscence

CCS

15

12

13

N/A

Success

  

25

54

F

LC (HBV, HDV)

D-D

Dehiscence

CCS

10

84

14

N/A

Success

  

26

53

F

LC (HCV)

D-D

Dehiscence

CCS

10

14

42

N/A

Success

  

27

63

M

LC (HBV)

D-D

Dehiscence

CCS

5

7

18

N/A

Success

  

28

68

F

LC (HBV)

D-D

Dehiscence

CCS

10

6

22

N/A

Success

  

29

54

M

LC (HBV)

D-D

Dehiscence

CCS

15

7

13

N/A

Success

2017

Saito et al. [23]

30

54

F

LC (PSC)

R-Y

Strangulated ileus

CDS

27

60

25

44

Success

2017

Parlak et al. [24]

31

68

F

LC (HCV)

D-D

Obstruction

CCS

2.5

14

7

36

Success

  

32

52

M

LC (HBV)

D-D

Obstruction

CCS

3

22

10

N/A

Success

  

33

55

M

LC (HBV)

D-D

Obstruction

CCS

4

16

2

36

Success

  

34

58

M

LC (Cryptogenic)

D-D

Obstruction

CCS

6

34

14

48

Success

  

35

38

F

LC (HBV)

D-D

Obstruction

CCS

3

38

12

48

Success

  

36

63

F

LC (HCV)

D-D

Obstruction

CCS

3

13

2

44

Success

  

37

52

M

LC (HBV)

D-D

Obstruction

CCS

4

60

10

N/A

Success

  

38

54

M

LC (HBV)

D-D

Obstruction

CCS

5

15

Failure

  

39

62

M

LC (Cryptogenic)

D-D

Obstruction

CCS

5

5

Failure

2018

Kubo

40

55

F

LC (PSC)

R-Y

Dehiscence

CJS

10

12

21

48

Success

       

Dehiscence

CJS

10

14

47

76

Success

 

Mean

 

51.6

 

s

   

8.9

22.6

35.5

37.6

36/40(90.0%)

  1. FH fulminant hepatitis, LC liver cirrhosis, HAV hepatitis type A virus, HBV hepatitis type B virus, HCV hepatitis type C virus, PSC primary sclerosing cholangitis, D-D duct-to-duct anastomosis, R-Y Roux en Y anastomosis, CCS choledochocholedochostomy, CDS choledochoduodenostomy, CJS choledochojejunostomy, N/A not addressed